
Aqtual
Developer of a novel analytical platform designed for cancer drug treatment. The company's platform captures disease molecular signals in circulating deoxyribonucleic acid to improve sensitivity, spec...
Valuation
$68.4M
Latest known
Share Price
N/A
Total Raised
$51.7M
Last Round
N/A